[Bronchial asthma: progress in diagnosis and treatments. Topics: III. Care and treatments; 3. Treatment for acute exacerbation of asthma]. 2013

Ryo Atsuta
Department of Respiratory Medicine, Juntendo University School of Medicine, Japan.

UI MeSH Term Description Entries
D004630 Emergencies Situations or conditions requiring immediate intervention to avoid serious adverse results. Emergency
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D017410 Practice Guidelines as Topic Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. Clinical Guidelines as Topic,Best Practices,Best Practice
D054539 Medication Therapy Management Assistance in managing and monitoring drug therapy for patients receiving treatment for cancer or chronic conditions such as asthma and diabetes, consulting with patients and their families on the proper use of medication; conducting wellness and disease prevention programs to improve public health; overseeing medication use in a variety of settings. Drug Therapy Management,MEDICARE Prescription Drug Improvement and Modernization Act of 2003,Management, Drug Therapy,Management, Medication Therapy,Therapy Management, Drug,Therapy Management, Medication
D018570 Risk Assessment The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988) Assessment, Risk,Benefit-Risk Assessment,Risk Analysis,Risk-Benefit Assessment,Health Risk Assessment,Risks and Benefits,Analysis, Risk,Assessment, Benefit-Risk,Assessment, Health Risk,Assessment, Risk-Benefit,Benefit Risk Assessment,Benefit-Risk Assessments,Benefits and Risks,Health Risk Assessments,Risk Analyses,Risk Assessment, Health,Risk Assessments,Risk Benefit Assessment,Risk-Benefit Assessments

Related Publications

Ryo Atsuta
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Ryo Atsuta
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Ryo Atsuta
July 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Ryo Atsuta
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Ryo Atsuta
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Ryo Atsuta
August 2011, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Ryo Atsuta
July 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Ryo Atsuta
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Ryo Atsuta
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Ryo Atsuta
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Copied contents to your clipboard!